Press releases
- Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
- Exact Sciences Earns 2024 Great Place To Work® Certification™
- Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
- Exact Sciences Announces First-Quarter 2024 Results
- Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
- Exact Sciences to Participate in May Investor Conference
- Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
- Exact Sciences Schedules First Quarter 2024 Earnings Call
- Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
- Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
More ▼
Key statistics
As of last trade Exact Sciences Corp (E2XA34:SAO) traded at 27.15, 3.55% above its 52-week low of 26.22, set on May 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 27.15 |
---|---|
High | 27.15 |
Low | 27.15 |
Bid | 26.73 |
Offer | 27.09 |
Previous close | 27.15 |
Average volume | 1.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of May 24 2024 15:36 BST.
More ▼